JP2001523717A - 異常細胞増殖、下痢および白痢によって特徴付けられる鎌状細胞病、炎症性の疾病を治療または予防するための置換ジフェニルインダノン、インダンおよびインドール化合物の使用 - Google Patents

異常細胞増殖、下痢および白痢によって特徴付けられる鎌状細胞病、炎症性の疾病を治療または予防するための置換ジフェニルインダノン、インダンおよびインドール化合物の使用

Info

Publication number
JP2001523717A
JP2001523717A JP2000521826A JP2000521826A JP2001523717A JP 2001523717 A JP2001523717 A JP 2001523717A JP 2000521826 A JP2000521826 A JP 2000521826A JP 2000521826 A JP2000521826 A JP 2000521826A JP 2001523717 A JP2001523717 A JP 2001523717A
Authority
JP
Japan
Prior art keywords
independently
substituted
aryl
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000521826A
Other languages
English (en)
Japanese (ja)
Inventor
ブルグナラ，カルロ
ハルペリン，ジョゼ
ベロット，エミール，エム．，ジュニア．
フロイモヴィッツ，マーク
ロンバルディー，リチャード，ジョン
クリフォード，ジョン，ジェイ．
ガオ，ユィング−デュオ
ハイダー，リーム，エム．
ケレハー，ユーネ，ダブリュ．
カー，ファルグニ，エム．
ムッサ，アデル，エム．
サシュデバ，イェッシュ，ピー．
サン，ミンガ
タフト，ヒーサー，エヌ．
レンサー，ウェイン，アイ．
アルパー，セス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/159,331 external-priority patent/US20020004519A1/en
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Publication of JP2001523717A publication Critical patent/JP2001523717A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
JP2000521826A 1997-11-20 1998-11-20 異常細胞増殖、下痢および白痢によって特徴付けられる鎌状細胞病、炎症性の疾病を治療または予防するための置換ジフェニルインダノン、インダンおよびインドール化合物の使用 Withdrawn JP2001523717A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US97559597A 1997-11-20 1997-11-20
US15933698A 1998-09-23 1998-09-23
US09/159,336 1998-09-23
US09/159,331 1998-09-23
US09/159,331 US20020004519A1 (en) 1998-09-23 1998-09-23 Method for reducing chloride secetion by intestinal epithlial cells in situ
US08/975,595 1998-09-23
PCT/US1998/024968 WO1999026624A1 (fr) 1997-11-20 1998-11-20 Utilisation de composes de diphenyle indanone, indane et indole substitues dans le traitement ou la prevention de la drepanocytose, des maladies inflammatoires caracterisees par une proliferation cellulaire anormale et par la diarrhee chez l'homme et l'animal

Publications (1)

Publication Number Publication Date
JP2001523717A true JP2001523717A (ja) 2001-11-27

Family

ID=27388300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000521826A Withdrawn JP2001523717A (ja) 1997-11-20 1998-11-20 異常細胞増殖、下痢および白痢によって特徴付けられる鎌状細胞病、炎症性の疾病を治療または予防するための置換ジフェニルインダノン、インダンおよびインドール化合物の使用

Country Status (6)

Country Link
EP (1) EP1032385A1 (fr)
JP (1) JP2001523717A (fr)
AU (1) AU1598899A (fr)
CA (1) CA2311129A1 (fr)
IL (1) IL136208A0 (fr)
WO (1) WO1999026624A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014524921A (ja) * 2011-07-22 2014-09-25 ヴェナンティウス・リミテッド 炎症性腸疾患の治療に使用するためのインデン誘導体

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800658B2 (en) 1997-11-20 2004-10-05 Children's Medical Center Corporation Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation
US6291449B1 (en) 1998-09-23 2001-09-18 Children's Medical Center Corporation Use of 11-phenyl-dibenzazepine compounds to treat diarrhea or scours
NL1034882C2 (nl) 2008-01-02 2009-07-06 Gear Chain Ind Bv Inrichting voor het rekken van een transmissieketting.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273992A (en) * 1992-11-02 1993-12-28 Beth Israel Hospital Assoc. Inc. Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ
EP0781128B1 (fr) * 1994-09-16 2005-11-23 Children's Medical Center Corporation Metabolites de clotrimazole contre la drepanocytose
AU6966696A (en) * 1995-10-05 1997-04-28 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
NZ332103A (en) * 1996-03-20 2000-08-25 Nuchem Pharmaceuticals Inc Triphenyl methane compounds or analogues thereof where one or more of the phenyl groups is substituted and the tertiary carbon atom is replaced for sickle cell disease,

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014524921A (ja) * 2011-07-22 2014-09-25 ヴェナンティウス・リミテッド 炎症性腸疾患の治療に使用するためのインデン誘導体

Also Published As

Publication number Publication date
IL136208A0 (en) 2001-05-20
WO1999026624A1 (fr) 1999-06-03
AU1598899A (en) 1999-06-15
CA2311129A1 (fr) 1999-06-03
EP1032385A1 (fr) 2000-09-06

Similar Documents

Publication Publication Date Title
US6331564B1 (en) Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
NZ183001A (en) 3-dimethylamin opropyl-3-phenyl-benzo(c)furans,and pharmaceutical compositions
CA2200084C (fr) Utilisation d&#39;halogenures aromatiques pour traiter la proliferation cellulaire mammalienne
JPWO2005079845A1 (ja) 片頭痛予防薬
JP2008201783A (ja) 鎌状赤血球症のためのトリアリールメタン化合物
JP2001523717A (ja) 異常細胞増殖、下痢および白痢によって特徴付けられる鎌状細胞病、炎症性の疾病を治療または予防するための置換ジフェニルインダノン、インダンおよびインドール化合物の使用
JP2001523720A (ja) 鎌状赤血球病、異常な細胞増殖によって特徴づけられる炎症性疾患、下痢症および伝染性下痢症の治療または予防用の置換１１−フェニル−ジベンザゼピン化合物の使用。
US6800658B2 (en) Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation
JP3790425B2 (ja) 異常な細胞増殖を特徴とする病気を治療および予防するための置換１１−フェニル−ジベンズアゼピン化合物
US20020128256A1 (en) Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferation
JP4009062B2 (ja) 異常な細胞増殖を特徴とする疾患を治療または予防するために有用な、置換ジフェニルインダノン、インダン、およびインドール化合物およびそれらの類縁体
JPH03135960A (ja) フェノキシ複素環式化合物
SU1398771A3 (ru) Способ получени замещенных бензамидов
US20030134842A1 (en) Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferation

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20060207